← Back to Search

Dietary Supplement

PrimaColl + Whey Protein for Collagen Synthesis Enhancement

N/A
Waitlist Available
Led By Keith Baar, PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (0 hour) to 4 hours after last exercise bout (at 28 hour of the protocol)

Summary

This trial tests if taking different types of collagen or protein supplements with vitamin C helps the body make more collagen. Healthy young adults aged 18-30 will take these supplements and do exercises. The study will measure how much new collagen is made to see if these supplements can help reduce injuries to ligaments, tendons, and bones. Collagen peptide supplements have been shown to improve body composition and strength when paired with resistance training.

Who is the study for?
This trial is for healthy, active men and women with a normal weight (BMI between 18-25). Participants should not have dietary restrictions affected by supplements, more than three muscle or bone injuries in the past year, or be on medication that could interfere with the study.
What is being tested?
The study tests how different supplements affect collagen production when taken before exercise. It compares vitamin C enriched hydrolyzed collagen, PrimaColl™, whey protein, and a placebo over a day with repeated doses and jump rope exercises.
What are the potential side effects?
Since this trial involves common food supplements and exercise, side effects are expected to be minimal. However, some may experience mild digestive discomfort or allergic reactions to ingredients.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (0 hour) to 4 hours after last exercise bout (at 28 hour of the protocol)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (0 hour) to 4 hours after last exercise bout (at 28 hour of the protocol) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Collagen protein synthesis
Secondary study objectives
Ligament collagen content
Strength of engineered ligaments

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: Whey ProteinExperimental Treatment1 Intervention
This arm will be given whey protein (20g with 50mg vitamin C)
Group II: PrimaCollExperimental Treatment1 Intervention
This arm will be given PrimaColl, a vegan collagen supplementation (20g with 50mg vitamin C)
Group III: Hydrolized CollagenExperimental Treatment1 Intervention
This arm will be given Hydrolized Collagen (20g with 50mg vitamin C)
Group IV: PlaceboPlacebo Group1 Intervention
This arm will be given a placebo (20g maltodextrin with 50mg vitamin C)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PrimaColl
2022
N/A
~20
Whey protein
2011
Completed Phase 4
~1180
Hydrolized Collagen
2022
N/A
~20

Find a Location

Who is running the clinical trial?

GeltorUNKNOWN
University of California, DavisLead Sponsor
944 Previous Clinical Trials
4,755,942 Total Patients Enrolled
Keith Baar, PhDPrincipal InvestigatorUC Davis
6 Previous Clinical Trials
134 Total Patients Enrolled

Media Library

Hydrolized Collagen (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05427279 — N/A
Food Supplement Effect Research Study Groups: Placebo, Hydrolized Collagen, PrimaColl, Whey Protein
Food Supplement Effect Clinical Trial 2023: Hydrolized Collagen Highlights & Side Effects. Trial Name: NCT05427279 — N/A
Hydrolized Collagen (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05427279 — N/A
~6 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top